In the field of chronic diseases, Type 2 diabetes ranks high when it comes to the challenges of therapy initiation and non-adherence. Diabetes accounts for $24.6 billion in wasteful and avoidable healthcare spending in the United States, and almost 50%…
Patient adherence programs are continually searching for more cost-effective interventions that improve clinical outcomes. Tactics have expanded beyond outreach by phone call to digital channels including emails and SMS text messages. In a trial of text and email interventions for…
Major mental health disorders are some of the most difficult conditions to manage. According to a retrospective analysis in Systematic Reviews, almost 450 million people are affected by mental health disorders worldwide, contributing 14% of the overall global burden of…
AllazoHealth continues to lead in advancing the use of artificial intelligence in healthcare. Building on our success in medication adherence, we have expanded our implementation of AI to include therapy initiation. Barriers to therapy initiation Therapy initiation is a critical…
2020 was dominated by the COVID-19 pandemic, and it will continue to dominate healthcare conversations this year. Looking back, how did the pandemic affect medication adherence? And what lessons were learned? Patient concerns about ability to pay Back in April,…
As the days tick down to the inauguration of President-elect Joseph Biden and Vice President-elect Kamala Harris, what will be the priorities of the new administration when it comes to U.S. healthcare? Let’s take a look. Handling the COVID-19 pandemic…
How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses more than $600 billion a…
When it comes to patient intervention programs to promote adherence, what are the best tactics? The right answer may be “all of them” – but it also depends on who is setting up the program. Pharmacies, payers, or pharmaceutical companies…
AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient behavior. Is using patient intervention…
